Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children

From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariani, Marcello, Caorsi, Roberta, Consolaro, Alessandro, Brisca, Giacomo, Sticchi, Camilla, Gattorno, Marco, Castagnola, Elio, Ravelli, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354361/
https://www.ncbi.nlm.nih.gov/pubmed/35927681
http://dx.doi.org/10.1186/s13052-022-01335-1
Descripción
Sumario:From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine.

Ejemplares similares